Efficacy of pertussis components in an acellular vaccine, as assessed in a murine model of respiratory infection and a murine intracerebral challenge model
- 28 November 2001
- Vol. 20 (9-10) , 1429-1434
- https://doi.org/10.1016/s0264-410x(01)00460-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Efficacy of chemically cross-linked antigens for acellular pertussis vaccineVaccine, 2000
- Efficacy of pertussis vaccines consisted of antigens detoxified with tea-leaf catechinsVaccine, 2000
- Informal Consultation with Manufacturers and WHO Ad Hoc Working Group on Mouse Protection Models for Acellular Pertussis Vaccines National Institute for Biological Standards, 12 November 1998Biologicals, 1999
- Current epidemiology of pertussis in JapanThe Pediatric Infectious Disease Journal, 1990
- Single-step purification of pertussis toxin and its subunits by heat-treated fetuin-Sepharose affinity chromatographyBiochemistry and Cell Biology, 1989
- Pertussis Vaccines in JapanPediatrics International, 1988
- Protective Activities of the Filamentous Hemagglutinin and the Lymphocytosis-Promoting Factor of Bordetella pertussis in MiceThe Journal of Infectious Diseases, 1984
- DEVELOPMENT OF A PERTUSSIS COMPONENT VACCINE IN JAPANThe Lancet, 1984
- A Simple Chemically Defined Medium for the Production of Phase I Bordetella pertussisJournal of General Microbiology, 1970
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970